Skip to content

Serum betatrophin levels and its influencing factors in patients with hyperthyroidism

Serum betatrophin levels and its influencing factors in patients with hyperthyroidism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-16008506
Enrollment
Unknown
Registered
2016-05-20
Start date
2016-05-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism

Interventions

Hyperthyroid Patients:Baseline anthropometric, biochemical and serum betatrophin level measurements, and antithyroid treatment
Control:Baseline anthropometric, biochemical and serum betatrophin level measurements

Sponsors

the First People's Hospital, Xuzhou, Jiangsu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All of the subjects were diagnosed with hyperthyroidism by typical clinical presentation, elevated serum TH, reduced TSH, and elevated serum TSH receptor antibody (TRAb) levels. All hyperthyroid patients were drug-naive before recruitment.

Exclusion criteria

Exclusion criteria: Subjects with the following conditions were excluded: diabetes, hypertension, cancer, pregnancy, lactation, subacute thyroiditis, postpartum thyroiditis, abnormal liver function, abnormal kidney function, and infectious diseases.

Design outcomes

Primary

MeasureTime frame
Serum betatrophin level;Thyroid function index;

Secondary

MeasureTime frame
blood lipid profile;liver function index;hypersensitive c-reactive protein (hs-crp);OGTT;insulin releasing test;BMI;Age;Sex;blood pressure;

Countries

China

Contacts

Public ContactWang Zhaoling

the First People's Hospital, Xuzhou, Jiangsu

dyywzl@126.com+86 13852103069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026